
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
Key Points
Key Points
Diagnosis
...Diagnosis...
...Newly Diagnosed...
...Onc...
...mmendation 1.1If a patient has node...
...ion 1.2In the group of patients in Recommendatio...
...dation 1.3In the group of patients i...
...n 1.4If a patient is postmenopausal and has n...
...ecommendation 1.5In the group of patients...
...1.6If a patient is premenopausal and has node-...
...1.7If a patient has node-positive breast canc...
...MammaPrint (7...
...ion 1.8If a patient is older than 50...
...tion 1.9If a patient is 50 years of ag...
...ommendation 1.10If a patient has low clinical ri...
...ommendation 1.11If a patient has nod...
...EndoPredict (1...
...tion 1.12If a patient is postmenopausal and h...
...commendation 1.13If a patient is pr...
...n 1.14If a patient has breast cancer with more tha...
...Prosigna (PAM50)...
...mmendation 1.15If a patient is postmenopausa...
...1.16If a patient is premenopausal, and h...
Recommendation 1.17If a patient is postmenopa...
...dation 1.18If a patient has node-positi...
...here is insufficient evidence to recommend u...
...Breast Ca...
...f a patient has ER-positive, HER2-negative,...
...nt has ER-positive, HER2-negative, node-...
...Ki67...
...dation 1.19If a patient is postmenopausal an...
...ation 1.20If a patient is postmenopausal and has b...
...1.21Despite the limitations associated with Ki67...
...Immunohistochemist...
...on 1.22If a patient has node-negative or n...
...ient has ER-positive, HER2-negative (node-neg...
...ient has HER2-positive breast cancer or tripl...
...Extende...
...Oncotype DX,...
Recommendation 1.23If a patient has node-negative...
...BCI...
...1.24If a patient has node-negative or node-pos...
...ation 1.25If a patient has node-positive...
...Clinical Treatment...
...ation 1.26If a patient is postmenopausal and...
...HER2-positive Breast Ca...
...Oncotype DX,...
...mendation 1.27If a patient has HER2-po...
...Emerging Bioma...
...Tumor-Infiltrating L...
...on 1.28If a patient has node-negativ...
...PD-L1 Testin...
...mmendation 1.29If a patient has node-negative...
...C...
...ecommendation 1.30If a patient has node-...
...Circulati...
...ation 1.31If a patient has node-negative o...
...1. Breast Cancer Biomarkers to Guide Adjuvant Th...
...gorithm on Biomarkers to Guide Decisions on Adjuva...
...ble 2. Classification of Patients A...
...believes that cancer clinical tria...